Professor Toumazou’s “lab-on-a-chip” technology decodes a patient’s DNA in under 30 minutes, enabling testing for genetic disease and drug intolerances on the spot. His invention represents a step towards illness prevention and targeted diagnosis.
Known for his silicon technology and integrated circuit design for electronic devices in medical diagnosis and therapy, Professor Toumazou has published many papers from his research in Electronics Letters and, as Editor, has overseen an increase in biomedical technology related content published in the journal. He highlighted some of the advances in this growing field through a special supplement to Electronics Letters: ‘Semiconductors in Personalised Medicine’, providing his overview of how semiconductor technology is being used for early detection and therapy of disease.
Professor Toumazou is Founder and Chief Scientist for the Institute of Biomedical Engineering at Imperial College, London. He is Regius Professor of Engineering, Chair in Biomedical Circuit Design, and Director of the Centre for Bio-Inspired Technology. He is also Founder, Chairman or CEO of two Medical Device Companies (Toumaz Technology and DNA Electronics) and Chief Scientific Advisor to GENEU.
